🔗 Permalink

Inventor profile of:

Wolfgang Schaefer

City:

Mannheim

Country:

Germany

Published Applications:

104

Last publication date:

2026-09-17

Top Assignees for applications by Wolfgang Schaefer

The entities that hold a legal rights for patent applications filed by inventor Schaefer Wolfgang:

HOFFMANN-LA ROCHE INC. 48 Little Falls, NJ United States
Hoffmann-La Roche Inc. 17 Nutley, NJ United States
Hoffman-La Roche. Inc. 6 Nutley, NJ United States
ROCHE GLYCART AG 3 Schlieren, Switzerland
Hoffman-La Roche Inc. 2 Little Falls, NJ United States
F. HOFFMANN-LA ROCNE AG 1 Basel, Switzerland
BRISTOL-MYERS SQUIBB COMPANY 1 Princeton, NJ United States
ENGMAB AG 1 Pfäffikon, Switzerland
ENGMAB AG 1 Wilen, Switzerland

Recent patent applications by Schaefer Wolfgang

Wolfgang Schaefer from Mannheim, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-09-17

US20260274936A1

Chemistry; metallurgy

HUMAN FCRN-BINDING MODIFIED ANTIBODIES AND METHODS OF USE

#2 | 2026-09-10

US20260265377A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#3 | 2026-07-23

US20260209326A1

Chemistry; metallurgy

MULTISPECIFIC ANTIBODIES

#4 | 2026-07-16

US20260201049A1

Chemistry; metallurgy

MULTISPECIFIC ANTIBODIES

#5 | 2026-02-19

US20260049160A1

Chemistry; metallurgy

TETRAVALENT MULTISPECIFIC ANTIBODIES

#6 | 2026-01-22

US20260022172A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#7 | 2025-09-25

US20250297025A1

Chemistry; metallurgy

BISPECIFIC ANTI-HUMAN A-BETA/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

#8 | 2025-07-10

US20250223372A1

Chemistry; metallurgy

BISPECIFIC ANTI-HUMAN A-BETA/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

#9 | 2024-09-26

US20240317879A1

Chemistry; metallurgy

BISPECIFIC ANTI-HUMAN CD20/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

#10 | 2024-05-02

US20240141044A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#11 | 2023-12-14

US20230399391A1

Chemistry; metallurgy

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES

#12 | 2023-11-16

US20230365702A1

Chemistry; metallurgy

BISPECIFIC ANTI-HUMAN A-BETA/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

#13 | 2023-09-14

US20230287118A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#14 | 2023-03-02

US20230068801A1

Chemistry; metallurgy

MULTISPECIFIC ANTIBODIES

#15 | 2022-12-22

US20220403027A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#16 | 2022-11-17

US20220363771A1

Chemistry; metallurgy

MULTISPECIFIC ANTIBODIES

#17 | 2022-10-13

US20220324955A1

Chemistry; metallurgy

FC-RECEPTOR BINDING MODIFIED ASYMMETRIC ANTIBODIES AND METHODS OF USE

#18 | 2022-09-29

US20220306761A1

Chemistry; metallurgy

Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use

#19 | 2022-05-12

US20220144963A9

Chemistry; metallurgy

Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use

#20 | 2022-02-17

US20220049020A1

Chemistry; metallurgy

TETRAVALENT MULTISPECIFIC ANTIBODIES

#21 | 2021-12-23

US20210395355A1

Chemistry; metallurgy

HUMAN FCRN-BINDING MODIFIED ANTIBODIES AND METHODS OF USE

#22 | 2021-10-07

US20210309730A1

Chemistry; metallurgy

MULTISPECIFIC ANTIBODIES

#23 | 2021-09-30

US20210301030A1

Chemistry; metallurgy

BISPECIFIC ANTI-HUMAN A-BETA/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

#24 | 2021-03-11

US20210070882A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#25 | 2021-02-18

US20210047394A1

Chemistry; metallurgy

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES

#26 | 2020-12-17

US20200392254A1

Chemistry; metallurgy

Multispecific antibodies

#27 | 2020-11-26

US20200369758A1

Chemistry; metallurgy

Bispecific antigen binding proteins

#28 | 2020-11-05

US20200347147A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#29 | 2020-09-17

US20200291131A1

Chemistry; metallurgy

Bispecific HER2 antibodies and methods of use

#30 | 2020-07-23

US20200231673A1

Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#31 | 2020-07-16

US20200223945A1

Chemistry; metallurgy

Three-dimensional structure-based humanization method

#32 | 2020-07-09

US20200216554A1

Chemistry; metallurgy

BISPECIFIC ANTI-HUMAN CD20/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

#33 | 2020-07-02

US20200207874A1

Chemistry; metallurgy

Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery

#34 | 2020-06-04

US20200172607A1

Chemistry; metallurgy

FC-RECEPTOR BINDING MODIFIED ASYMMETRIC ANTIBODIES AND METHODS OF USE

#35 | 2020-03-26

US20200095310A1

Chemistry; metallurgy

Fc-receptor binding modified asymmetric antibodies and methods of use

#36 | 2019-05-23

US20190153071A1

Chemistry; metallurgy

Bivalent, bispecific antibodies

#37 | 2018-11-01

US20180312573A1

Chemistry; metallurgy

Nucleic acid encoding dual Fc antigen binding proteins

#38 | 2018-10-04

US20180282410A1

Chemistry; metallurgy

ANTI-CD3XROB04 BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#39 | 2018-08-09

US20180222993A1

Chemistry; metallurgy

Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use

#40 | 2018-08-09

US20180222992A1

Chemistry; metallurgy

Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use

#41 | 2018-08-09

US20180222981A1

Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#42 | 2018-08-09

US20180222980A1

Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#43 | 2018-03-22

US20180079805A1

Chemistry; metallurgy

Bispecific antigen binding proteins

#44 | 2018-02-08

US20180037633A1

Chemistry; metallurgy

Monovalent antigen binding proteins

#45 | 2017-12-28

US20170369595A1

Chemistry; metallurgy

Multispecific antibodies

#46 | 2017-12-28

US20170369566A1

Chemistry; metallurgy

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES

#47 | 2017-12-07

US20170349669A1

Chemistry; metallurgy

MULTISPECIFIC ANTIBODIES

#48 | 2017-10-26

US20170306044A1

Chemistry; metallurgy

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND ROR1 FOR USE IN THE TREATMENT OF OVARIAN CANCER

#49 | 2017-10-26

US20170306036A1

Chemistry; metallurgy

Bispecific antibodies against CD3ϵ and BCMA

#50 | 2017-10-26

US20170306018A1

Chemistry; metallurgy

Bispecific antibodies against CD3EPSILON and ROR1

#51 | 2017-08-17

US20170233490A1

Chemistry; metallurgy

HER3/HER2 bispecific antibodies binding to the beta-hairpin of HER3 and domain II of HER2

#52 | 2017-07-13

US20170198043A1

Chemistry; metallurgy

BISPECIFIC ANTIGEN BINDING MOLECULES

#53 | 2017-07-06

US20170190783A1

Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#54 | 2017-06-22

US20170174786A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#55 | 2017-05-25

US20170145116A1

Chemistry; metallurgy

TETRAVALENT MULTISPECIFIC ANTIBODIES

#56 | 2017-05-11

US20170129962A1

Chemistry; metallurgy

MULTISPECIFIC ANTIBODIES

#57 | 2017-02-02

US20170029529A1

Chemistry; metallurgy

Bispecific HER2 antibodies and methods of use

#58 | 2016-11-03

US20160319036A1

Chemistry; metallurgy

Multispecific domain exchanged common variable light chain antibodies

#59 | 2016-07-07

US20160194389A1

Chemistry; metallurgy

FC-RECEPTOR BINDING MODIFIED ASYMMETRIC ANTIBODIES AND METHODS OF USE

#60 | 2016-06-09

US20160159894A1

Chemistry; metallurgy

Human FcRn-binding modified antibodies and methods of use

#61 | 2016-06-02

US20160151487A1

Human necessities

FCRN-BINDING ABOLISHED ANTI-IGF-1R ANTIBODIES AND THEIR USE IN THE TREATMENT OF VASCULAR EYE DISEASES

#62 | 2016-03-17

US20160075785A1

Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#63 | 2016-03-10

US20160068613A1

Chemistry; metallurgy

FC-RECEPTOR BINDING MODIFIED ASYMMETRIC ANTIBODIES AND METHODS OF USE

#64 | 2015-11-05

US20150315296A1

Chemistry; metallurgy

MULTISPECIFIC ANTIBODIES

#65 | 2015-06-18

US20150166670A1

Chemistry; metallurgy

MULTISPECIFIC ANTIBODIES

#66 | 2015-02-12

US20150044214A1

Chemistry; metallurgy

BISPECIFIC, TETRAVALENT ANTIGEN BINDING PROTEINS

#67 | 2015-01-29

US20150030598A1

Chemistry; metallurgy

TRI- OR TETRASPECIFIC ANTIBODIES

#68 | 2015-01-01

US20150004166A1

Chemistry; metallurgy

Bispecific anti-VEGF/anti-ANG-2 antibodies

#69 | 2014-05-01

US20140120613A1

Chemistry; metallurgy

BIVALENT, BISPECIFIC ANTIBODIES

#70 | 2013-12-26

US20130344094A1

Chemistry; metallurgy

POLYPEPTIDE-POLYNUCLEOTIDE-COMPLEX AND ITS USE IN TARGETED EFFECTOR MOIETY DELIVERY

#71 | 2013-10-17

US20130273054A1

Chemistry; metallurgy

Bispecific Anti ErbB2/Anti cMet Antibodies

#72 | 2013-06-20

US20130156772A1

Chemistry; metallurgy

Bispecific Anti ErbB1 / Anti cMet Antibodies

#73 | 2013-03-07

US20130060011A1

Chemistry; metallurgy

FC-FREE ANTIBODIES COMPRISING TWO FAB FRAGMENTS AND METHODS OF USE

#74 | 2013-03-07

US20130058937A1

Chemistry; metallurgy

Bispecific antigen binding molecules

#75 | 2012-12-20

US20120321627A1

Chemistry; metallurgy

Bispecific anti-VEGF/anti-ANG-2 antibodies

#76 | 2012-09-20

US20120237507A1

Chemistry; metallurgy

Monovalent Antigen Binding Proteins

#77 | 2012-09-20

US20120237506A1

Chemistry; metallurgy

Dual FC antigen binding proteins

#78 | 2012-09-06

US20120225071A1

Chemistry; metallurgy

Bivalent, bispecific antibodies

#79 | 2012-06-28

US20120164726A1

Chemistry; metallurgy

BIVALENT, BISPECIFIC ANTIBODIES

#80 | 2012-06-14

US20120149879A1

Chemistry; metallurgy

BISPECIFIC ANTI-EGFR/ANTI-IGF-1R ANTIBODIES

#81 | 2011-09-29

US20110236388A1

Chemistry; metallurgy

Bispecific, bivalent anti-VEGF/anti-ANG-2 antibodies

#82 | 2010-12-23

US20100322935A1

Chemistry; metallurgy

Tri- or tetraspecific antibodies

#83 | 2010-12-23

US20100322934A1

Chemistry; metallurgy

Bispecific, tetravalent antigen binding proteins

#84 | 2010-12-16

US20100316645A1

Chemistry; metallurgy

Bispecific antigen binding proteins

#85 | 2010-10-07

US20100254989A1

Human necessities

Bispecific Anti ErbB1 / Anti c Met Antibodies

#86 | 2010-10-07

US20100254988A1

Human necessities

Bispecific Anti ErbB2 / Anti cMet Antibodies

#87 | 2010-05-06

US20100111967A1

Chemistry; metallurgy

Bispecific anti-VEGF/anti-ANG-2 antibodies

#88 | 2010-04-01

US20100081796A1

Chemistry; metallurgy

BISPECIFIC ANTI-EGFR/ANTI-IGF-1R ANTIBODIES

#89 | 2010-02-18

US20100041684A1

Chemistry; metallurgy

Pyrimidyl derivatives as protein kinase inhibitors

#90 | 2009-12-24

US20090318428A1

Chemistry; metallurgy

Imidazo [4,5-B] pyridine and pyrrolo [2,3-B] pyridine protein kinase inhibitors

#91 | 2009-10-01

US20090247518A1

Chemistry; metallurgy

6-(2-ALKYL-PHENYL)-PYRIDO[2,3-D]PYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS

#92 | 2009-09-17

US20090232811A1

Chemistry; metallurgy

Bivalent, bispecific antibodies

#93 | 2009-09-10

US20090227578A1

Chemistry; metallurgy

Azabenzimidazole Derivatives, Their Manufacture and Use as Anti-Cancer Agents

#94 | 2009-07-09

US20090175851A1

Chemistry; metallurgy

Bivalent, bispecific antibodies

#95 | 2009-06-25

US20090162360A1

Chemistry; metallurgy

Bivalent, bispecific antibodies

#96 | 2009-06-25

US20090162359A1

Chemistry; metallurgy

BIVALENT, BISPECIFIC ANTIBODIES

#97 | 2009-01-29

US20090030020A1

Chemistry; metallurgy

7H-pyrido[3,4-D]pyrimidin-8-ones, their manufacture and use as protein kinase inhibitors

#98 | 2008-02-14

US20080039460A1

Chemistry; metallurgy

Benzamide derivatives, their manufacture and use as pharmaceutical agents

#99 | 2008-02-07

US20080032970A1

Chemistry; metallurgy

Amide derivatives of 7-amino-3-phenyl-dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents

#100 | 2008-01-10

US20080009492A1

Chemistry; metallurgy

Heterocyclic carbamate derivatives, their manufacture and use as pharmaceutical agents

InventorID:

126883 ⎘